Liver and intrahepatic bile duct neoplasm
Therapeutic area
Endocrinology
Rare disease
No
- Definition
- A benign or malignant neoplasm that affects the liver parenchyma or intrahepatic bile ducts. Representative examples of benign neoplasms include hepatocellular adenoma, and bile duct adenoma. Representative examples of malignant neoplasms include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and lymphoma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Liver and intrahepatic bile duct neoplasm
- Therapeutic area
- Endocrinology
- liver and intrahepatic bile duct neoplasm
- epithelial hepatic and intrahepatic bile duct neoplasm
- hepatic and intrahepatic bile duct neoplasm
- liver and intrahepatic bile duct epithelial neoplasm
- liver and intrahepatic bile duct neoplasm
- liver neoplasm
- liver neoplasm (disease)
- liver tumor
- liver tumour
- neoplasm of liver
- tumor of liver
- tumour of liver
- Severity
- Severe
- Endocrinology
- Gastroenterology
- Oncology
- MONDO ID
- MONDO:0024477
- Parent condition
- MONDO:0002082
Related records
Broader conditions (14)
- Cancer or benign tumor
- Digestive system disorder
- Digestive system neoplasm
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Endocrine gland neoplasm
- Endocrine system disorder
- Hepatobiliary disorder
- Hepatobiliary neoplasm
- Human disease
- Liver disorder
- Neoplasm
- Neoplastic disease or syndrome
Narrower conditions (114)
- Adenocarcinoma of gallbladder and extrahepatic biliary tract
- Adenosquamous bile duct carcinoma
- Adult hepatocellular carcinoma
- Aflatoxin-related hepatocellular carcinoma
- Ampulla of vater adenocarcinoma
- Ampulla of vater adenosquamous carcinoma
- Ampulla of vater cancer
- Ampulla of vater clear cell adenocarcinoma
- Ampulla of vater mucinous adenocarcinoma
- Ampulla of vater neoplasm
- Ampulla of vater small cell neuroendocrine carcinoma
- Ampulla of vater squamous cell carcinoma
- Ampullary signet ring cell adenocarcinoma
- Bile duct adenocarcinoma
- Bile duct adenoma
- Bile duct cancer
- Bile duct carcinoma
- Bile duct carcinoma in situ
- Bile duct cystadenoma
- Bile duct mucinous cystic neoplasm with an associated invasive carcinoma
Trials (1,327)
- "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
- (3D) Ultrasound Imaging Liver and Kidney
- [18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity
- 18F-DCFPyL PET/CT in Hepatocellular Carcinoma
- 3D Liver Volumetry
- 3D Printed Models for Liver Surgery
- 4D Phase Contrast MR: Hypertrophy in Liver Cancer
- 4D-MRI for Precision Medicine
- 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
- A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer
- A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
- A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
- A Clinical Study of Precision TACE (P-TACE) With Surefire
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
- A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support
- A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
- A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
- a Cohort Study (Gut Microbiota and HCC)
- A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
Drugs in development (1)
- Lenvatinib Phase 2
Other linked drugs (1)
- Gadoxetate disodium